In a report released yesterday, Matthew Biegler from Oppenheimer reiterated a Buy rating on Nurix Therapeutics (NRIX – Research Report), with a ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

Immune cells called regulatory T cells have long been known for their role in countering inflammation. In the setting of ...

BTIG analysts began covering Arcturus Therapeutics (NASDAQ:ARCT) with a positive outlook, assigning a Buy rating and establishing a price target of $41.00. Currently trading at $16.49 with a market ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Enhances B Cell Responses in Type 2 Inflammation Through IL-17RB Receptor,” published in the January 2025 issue of Allergy ...

Lower Mainlanders are still reeling over the loss of AM 730. Metro Vancouver’s all-traffic station provided live reports on ...

Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.

DES MOINES — Iowa Gov. Kim Reynolds released her proposal to state lawmakers Friday to ban cell phone use in classrooms.